- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT05852951
Cycle and Ovulation Study Expansion
May 1, 2023 updated by: Apple Inc.
The objective of this study was to collect menstrual cycle, health sensor data and general health information to understand correlations between menstrual cycle and health sensor data, and how those correlations may be affected by general health.
Participants entered menstrual cycle information (such as start dates, end dates, symptoms, flow), basal body temperature as measured by a thermometer, and ovulation and progesterone test results via apps installed on their iPhone.
Additionally, participants were provided with an Apple Watch and a wrist-worn hardware prototype wrist-worn sleep band to collect physiological sensor data.
Both menstrual cycle information and physiological sensor data stored on the participants' iPhone prior to enrolling in the study (up to 18 months) was also collected.
This study aimed to collect data from females aged 14 and older who are currently menstruating with irregular and regular menstrual cycles.
Study Overview
Status
Completed
Conditions
Study Type
Observational
Enrollment (Actual)
698
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Arizona
-
Phoenix, Arizona, United States, 85027
- Exponent
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Contract research organization
Description
- At least 14 years of age (19 for residents of Alabama and Nebraska and 21 for residents of Mississippi)
- Can communicate in written and spoken English
- Own functioning iPhone iOS 14 or later, with access to reliable data plan and Wifi
- Access to reliable Wifi in the bedroom
- Willingness to participate in remote visits and follow study procedures for the duration of the study, including use of Apple Watch and a wrist-work hardware prototype
- Able to read and understand the written consent form
- Reside in the US for the duration of the study
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
|---|
|
Menstrual patterns
Regular menstrual cycles and irregular menstrual cycles; irregular menstrual cycles are defined as having variation in menstrual cycles of greater than 2 days and less than 2 months
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Retrospective ovulation day estimate
Time Frame: 12 months
|
Retrospective ovulation day estimation (algorithm uses multiple measurements including menstrual flow, urine ovulation prediction testing, basal body temperature, overnight aggregated wrist temperature)
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Collaborators
Investigators
- Principal Investigator: Bo Qing, PhD, Exponent
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 9, 2021
Primary Completion (Actual)
May 23, 2022
Study Completion (Actual)
May 23, 2022
Study Registration Dates
First Submitted
March 7, 2023
First Submitted That Met QC Criteria
May 1, 2023
First Posted (Actual)
May 10, 2023
Study Record Updates
Last Update Posted (Actual)
May 10, 2023
Last Update Submitted That Met QC Criteria
May 1, 2023
Last Verified
May 1, 2023
More Information
Terms related to this study
Keywords
Other Study ID Numbers
- Pro00054031
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Menstruation
-
Clinical Research Centre, MalaysiaTwin Catalyst Sdn. Bhd.Completed
-
Institut National de la Santé Et de la Recherche...Recruiting
-
Essity Hygiene and Health ABActive, not recruiting
-
University of British ColumbiaNational Research System-College of Family Physicians of CanadaCompleted
-
Pamukkale UniversityRecruitingMenstruation; SyndromeTurkey
-
Meditrina PharmaceuticalsCompletedMenstruation DisordersUnited States
-
Institut National de la Santé Et de la Recherche...Completed